| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |